Drug profile · INN
icosapent ethyl
VAZKEPA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
icosapent ethyl (VAZKEPA) is an FDA-listed pharmaceutical active ingredient. Associated with Seqirus (Australia) Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN icosapent ethyl
Brand VAZKEPA
Route ORAL
Formulation CAPSULE
ATC code C10AX
Originator Seqirus (Australia) Pty Ltd
Frequently asked questions
What is icosapent ethyl?
icosapent ethyl (VAZKEPA) is an FDA-listed pharmaceutical active ingredient. Associated with Seqirus (Australia) Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for icosapent ethyl?
VAZKEPA is a marketed brand name for icosapent ethyl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of icosapent ethyl?
icosapent ethyl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.